Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren's Disease: A Retrospective Cohort Study

Boriani, Filippo
Primo
;Gustar, Adrian;Figus, Andrea
Ultimo
2022-01-01

Abstract

An underdosing of collagenase clostridium histolyticum (0.32 mg) is proposed as a potentially effective option in patients with additional cords in the same hand, after the first cord has been treated with the regular dose of 0.58 mg. The aim of this study was to analyze whether this additional dose is tolerated and effective.
2022
Inglese
10
11
4659
WOS:000886634300008
36438471
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682618/
Esperti anonimi
scientifica
Goal 3: Good health and well-being
no
Boriani, Filippo; Raggini, Filippo; Evangelista, Andrea; Gustar, Adrian; Figus, Andrea
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
5
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie